loader from loading.io

In the News.. BG trends during COVID lockdowns, diabetes sales fraud, A Dexcom G5 message, and more!

Diabetes Connections | Type 1 Diabetes

Release Date: 09/17/2021

Do We Need an At-Home A1C Test in the  Age of CGM? Orange Biomed Says Yes show art Do We Need an At-Home A1C Test in the Age of CGM? Orange Biomed Says Yes

Diabetes Connections | Type 1 Diabetes

Making the case for a better at home A1C test. Orange Biomed is developing a compact, one-drop, at-home A1C testing device they say could make frequent A1C checks easier and more accessible than ever. They’re passionate about closing the gap for people who struggle to get to clinics regularly… and the research they share is compelling: four A1C tests a year can lead to a nearly 4% reduction in A1C levels. We’ll talk about why more frequent A1C monitoring matters—even in the era of continuous glucose monitoring—how their new device works, and what early clinical trial results look...

info_outline
She Turned Her Glucose Data Into Art. Could it Change How People See Diabetes? show art She Turned Her Glucose Data Into Art. Could it Change How People See Diabetes?

Diabetes Connections | Type 1 Diabetes

What if your glucose graph became a tangible piece of art? Something you could pring out and put on your water bottle or the back of your laptop. I’ve seen this in person and it makes a big impact on people. This week I’m talking to Krista Shenaman about making this type of art, her journey with type 2 – and it’s been a journey, she took a “record breaking” 28 day walk after her diagnosis.. – why she thinks its helpful to look at data in a new way and more.    Full disclosure: We recorded this interview way back in 2024! Technical issues and thought it was lost,...

info_outline
Dexcom’s 15-Day G7 Is Here: What’s Changing, What’s Next, and What You Need to Know show art Dexcom’s 15-Day G7 Is Here: What’s Changing, What’s Next, and What You Need to Know

Diabetes Connections | Type 1 Diabetes

It’s been a big month for announcements from Dexcom! What does that mean for you?  From the commercial launch of the 15 day sensor and a smart basal feature to the announced phase out of the G6 and more, I’m talking with Jessica Castle, vice president of Global Medical Affairs at Dexcom. We’re covering all of this news and she’s answering your questions. More about More about This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to  Learn more about ...

info_outline
Inside Capitol Hill’s Fight for Diabetes Care: What These Advocates Need You to Know show art Inside Capitol Hill’s Fight for Diabetes Care: What These Advocates Need You to Know

Diabetes Connections | Type 1 Diabetes

We're looking at some major policy issues happening in Washington, and what you can really do to effect change. George Huntley is the CEO of . We’ve got a lot to cover: Medicare changes like competitive bidding that could dramatically limit access to CGMs and insulin pumps for seniors, the changing landscape around GLP 1 meds, and we talk about patient advocacy wins. I know some of you are cynical, but it can work. If you’ve ever thought your voice doesn’t matter, this conversation may change your mind. This podcast is not intended as medical advice. If you have those kinds of questions,...

info_outline
In the News... Libre Freestyle recall, Dexcom 15 day launch, Omnipod & Tandem updates, Medicare price adjustments and more! show art In the News... Libre Freestyle recall, Dexcom 15 day launch, Omnipod & Tandem updates, Medicare price adjustments and more!

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big FDA recall around Freestyle Libre (see more below to find out if you're affected), Dexcom launches their 15.5 day sensor, Omnipod announces enhancements, Tandem tests a fully closed loop (with high fat, high carb meals) and lots more! Find out  Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up with Stacey and the show is by...

info_outline
Preventing Type 1 Diabetes? Dr. Michael Haller on ATG Research (Plus, Afrezza for Kids) show art Preventing Type 1 Diabetes? Dr. Michael Haller on ATG Research (Plus, Afrezza for Kids)

Diabetes Connections | Type 1 Diabetes

We've got a research update on two of the topics you’ve told me you want to hear more about. First, research into Preventing type 1 – with a therapy that hasn’t been in the headlines.. and second, inhaled insulin for kids. We’re talking to , a peds endo who is at the forefront of these studies. We’ll be talking about something called ATG – which looks really good in very low dose trials – and about the latest studies around inhaled insulin for kids – which is in front of the FDA right now. This podcast is not intended as medical advice. If you have those kinds of questions,...

info_outline
Rethinking Type 1 Screening with Adam Schefter & Dr. Shara Bialo show art Rethinking Type 1 Screening with Adam Schefter & Dr. Shara Bialo

Diabetes Connections | Type 1 Diabetes

With lots of family time coming up this week for many of us, it’s a great time to talk about screening for type 1. While this might seem to be a real downer of a Thanksgiving conversation, screening is now considered standard of care for people with a family history of T1D. My guests want to get the word out about that – and they’ve both walked the walk. Adam Schefter is ESPN Senior NFL Insider – his wife lives with type 1.. and Dr. Shara Bialo is a pediatric endo who lives with type 1. This podcast is not intended as medical advice. If you have those kinds of questions, please contact...

info_outline
Diabetes Sports Project: Competing at the highest levels with type 1 diabetes show art Diabetes Sports Project: Competing at the highest levels with type 1 diabetes

Diabetes Connections | Type 1 Diabetes

The Diabetes Sprots project says it’s an organization built to inspire. What can we all learn about elite athletes with type 1 – the people running marathons and doing Iron Man competitions. And with the right support and education, how far can those athletes go? We’re talking about the Olympics and more with DSP founder Casey Boren and volunteer Lauren Adams, both of whom live with type 1 (and both of whom had done a ten mile run before we started taping). Learn more about This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health...

info_outline
In the News... It's World Diabetes Day! Top stories and headlines for Nov 14, 2025 show art In the News... It's World Diabetes Day! Top stories and headlines for Nov 14, 2025

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly...

info_outline
Inside Tandem’s Latest: catching up with VP of Product Management Marisa Fienup show art Inside Tandem’s Latest: catching up with VP of Product Management Marisa Fienup

Diabetes Connections | Type 1 Diabetes

We've got an update from Tandem Diabetes. We’re talking about Libre 3 plus integration, Lyumjev approval, Mobi tubeless, extended wear infusion sets and a lot more with VP of Product Management Marisa Fienup. She’s also answering your questions about tubing, alerts, and shares what’s next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to Information and Learn more about  Please visit our Sponsors & Partners - they help make the show...

info_outline
 
More Episodes

It's In the News... the top diabetes stories of the past seven days! This week, what did lockdown mean for BG trends, Provention Bio keeps fighting for Teplizumab, the FTC shuts down diabetes schlockmeisters and if you're still using the Dexcom G5 - you need to hear this...

Join Stacey live on Facebook each Wednesday at 4:30pm EDT to watch live.

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Get the App and listen to Diabetes Connections wherever you go!

Click here for iPhone      Click here for Android

Episode transcription and links below

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.  As always, I’m going to link up my sources in the Facebook comments – where we are live – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more if you want, on your own schedule.

XX

In the News is brought to you by Real Good Foods! Find their Entrée Bowls and all of their great products in your local grocery store, Target or Costco.

XX

Our top story.. What did COVID lockdown mean for blood sugar trends? A new study says when they had to stay at home, people with type 1 significantly improved while the opposite happened for those with type 2.

You should know these studies all come from European countries with pretty strict lockdowns and they’re an aggregate – a look at a bunch of previously conducted studies.

With type 1, time in range improved significantly in 83% of the studies looked at here.. with type 2, almost half of the studies showed a clear decrease in blood sugar control, with higher A1Cs.

So what happened? There’s a lot of speculation but these researchers suggest less exercise and more snacking and more stress is to blame for the type 2 numbers..  although in my opinion the same could be said for all people with diabetes. They also suppose that the lockdown gave parents more time to look after kids with type 1 and gave young adults a more predictable routine.

I hope another study is done on this in the US where, frankly – access to insulin & health care providers may have become more of an issue during the pandemic

https://www.news-medical.net/news/20210913/COVID-19-lockdown-linked-to-improved-glycemic-control-in-type-1-diabetes.aspx

XX

Bit of an update - Provention Bio moving forward to answer the FDA’s questions and hopefully resubmit. This is for Teplizumab the first drug shown to prevent type 1 diabetes for – so far- up to three years.. although the FDA turned it down in July.

Provention says they continue to collect data and are moving to set up what’s called a Formal Type A meeting to submit that new information.

The company’s CEO says they believe they’re making significant progress to address the observations cited by the FDA and continue to work with urgency.

 

https://finance.yahoo.com/news/provention-bio-provides-potential-timing-113000253.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

 

XX

Bunch of schlock-meisters got called out last week by the US FDA and FTC – that’s the Federal Trade Commission. 10 companies got warning letters alleging they were selling illegal dietary supplements to cure or prevent diabetes. Regulators wrote the products cited in the warning letters are considered unapproved new drugs – they include things like turmeric, bitter melon, ginkgo biloba and more.. The report cites the increasing cost of insulin and other diabetes medications as a reason why people are turning to alternatives, even if they aren’t proven.. Please.. be careful out there.

https://www.naturalproductsinsider.com/supplements/regulators-target-diabetes-supplements-recent-warnings-about-claims

 

Quick additional FTC note – they held a virtual open meeting today. Two people from the diabetes community spoke about rising insulin prices. If you’d like to learn more I’ll link up the information.

https://www.ftc.gov/news-events/press-releases/2021/09/ftc-announces-tentative-agenda-september-15-open-commission

XX

We don’t talk a lot about shots – multiple daily injections – but here’s some good news about the basics. New study shows rotating sites and using smaller needles really do help. You’ve likely heard of LY-po-hy-PER-tro-fee.. it’s when lumps of fat or scar tissue form under your skin. These Belgian researchers did a six month study where they provided smaller pen needles and did a lot of education, including an online platform where they taught proper injection techniques, including not re-using needles. They reduced what they called unexplained high blood glucose significantly and glucose variability decreased as well. A1Cs stayed about the same.

https://onlinelibrary.wiley.com/doi/10.1111/dme.14672

XX

No surprise but still disappointing –  insurance is what’s dictating whether young children are more likely to use a CGM regularly. This was published in Diabetes Technology & Therapeutics.

Those on public or government insurance often face more obstacles.

This was a study of children ages 1-6 years, within two months of diagnosis.

82-percent used a CGM at least once during the study period.. but they divided everyone into 4 groups – always used CGM, stable use, inconsistent use or never used.

Families with private insurance were more likely to be in the always group or the stable group than those with public insurance. And..

The “always” group had an A1C that was 1.3% lower than the “never” group

https://www.healio.com/news/endocrinology/20210907/private-insurance-determines-cgm-use-by-young-children-with-type-1-diabetes

XX

More to come, including a Dexcom G5 update! But first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible.

Real Good Foods. Where the mission is Be Real Good

They make nutritious foods— grain free, high in protein, never added sugar and from real ingredients—the new Entrée bowls are great. They have a chicken burrito, a cauliflower mash and braised beef bowl.. the lemon chicken I’ve told you about and more! They keep adding to the menu line! You can buy online or find a store near you with their locator right on the website. I’ll put a link in the FB comments and as always at d-c dot com.

Back to the news…

Heads up if you’re still – somehow – using the Dexcom G5. More than a year ago, Dexcom stopped selling the G5 and G4.. but – and thanks to the listeners who brought this to my attention – the G5 app is now sending out a notification.. On October 4th the Dexcom G5 app will no longer be available. As they’ve shared with us on the podcast many times, they’ve been transitioning everyone over to the G6 and will soon move on to the G7. No timeline on that btw I know you’re going to ask. But as far as we know, it hasn’t been submitted to the FDA and Dexcom has said it will go for European approval first.

--

And finally don’t forget to send me your Dear Dr. Banting audio! What would you say to the man credited with the discovery of insulin? All the details and how to send it to me is in the show notes.

--

Please join me wherever you get podcasts for our next episode - The episode out right now is all about the new Walmart Insulin.. will it save you money?

That’s In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.